High Mobility Group Protein I(Y) as a Marker for Prostate Cancer Progression
Author Information
Author(s): Y Tamimi, HG van der Poell, HFM Karthaus, FMJ Debruyne, JA Schalken
Primary Institution: University Hospital Nijmegen
Hypothesis
High mobility group protein I(Y) might be a potential prognostic marker in prostate cancer.
Conclusion
High HMG-I(Y) levels are indicative of a worse prognosis in prostate cancer patients.
Supporting Evidence
- 75% of samples showed appropriate RNA preservation.
- High HMG-I(Y) expression was found in 87% of recurrent tumors.
- Statistically significant differences in HMG-I(Y) expression levels were found between all groups.
Takeaway
This study looked at a protein that might help doctors predict how bad prostate cancer will get. They found that higher levels of this protein usually mean the cancer is more serious.
Methodology
The study analyzed HMG-I(Y) mRNA expression in paraffin-embedded archival material from 102 patients using RNA in situ hybridization.
Limitations
The study relied on archival material, which may limit the accuracy of the findings.
Participant Demographics
Patients undergoing radical prostatectomy for prostate cancer.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website